Thomas Helmut 4
4 · TRANZYME INC · Filed Apr 21, 2011
Insider Transaction Report
Form 4
TRANZYME INCTZYM
Thomas Helmut
Senior VP, R&D
Transactions
- Award
Stock Option (right to buy)
2011-04-19+78,641→ 78,641 totalExercise: $4.00Exp: 2021-04-19→ Common Stock (78,641 underlying)
Footnotes (1)
- [F1]25% of the shares will vest and become exercisable on April 19, 2012, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter.